Home » Economy » Pharma – Novartis drug Kymriah receives FDA approval

Pharma – Novartis drug Kymriah receives FDA approval

Wednesday, August 30th, 2017 | Economy

The US health authority FDA has granted approval for the drug Kymriah (Tisagenlecleucel, CTL019) from Novartis. This is the first gene therapy approved in the US.

Related

Rihanna Pon De Replay Lyrics

Rihanna Pon De Replay Lyrics Rihanna Pon De Replay Lyrics Vlogs Yellow Claw

Bitcoin Price Monthly Chart

Bitcoin Price Monthly Chart The CoinDesk Bitcoin Price Index provides the latest and

Chris Cornell Died

Chris Cornell Died Chris Cornell Died Vlogs Navy SEAL Releases Evidence Chris Cornell

Swiss jobs - Companies do not shake thei

The net labor market forecast for the fourth quarter is zero percent, as